Thursday, April 15, 2021

Five RADx-UP-related Funding Opportunity Announcements

Research Funds Toward Community-engaged and School Return COVID-19 Testing; Implications of COVID-19 Testing Disparities; Vaccine Hesitancy

Having trouble viewing this email? View it as a Web page.

Updates

Five RADx-UP-related Funding Opportunity Announcements


Emergency Awards: Community-engaged COVID-19 Testing Interventions Among Underserved and Vulnerable Populations – RADx-UP Phase II (U01 Clinical Trial Optional)

NIH Guide Number: RFA-OD-21-008

Go to RFA Details
 

Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-engaged COVID-19 Testing Interventions Among Underserved and Vulnerable Populations – RADx-UP Phase II (Emergency Supplement - Clinical Trial Optional)

NIH Guide Number: NOT-OD-21-103

Go to NOSI Details
 

Emergency Award: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing Among Underserved and Vulnerable Populations (U01 Clinical Trials Optional)

NIH Guide Number: RFA-OD-21-009

Go to RFA Details
 

Notice of Special Interest (NOSI): Administrative Supplements for Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) Phase I Projects to Address Vaccine Hesitancy and Uptake

NIH Guide Number: NOT-OD-21-101

Go to NOSI Details
 

Notice of Intent to Publish a Research Opportunity Announcement for RADx-UP Return to School Diagnostic Testing Approaches (OT2 Clinical Trial Optional)

NIH Guide Number: NOT-OD-21-097

Go to NOITP Details
 


This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute on Minority Health and Health Disparities · 6707 Democracy Boulevard · Suite 800 · Bethesda, MD · 20892-5465 GovDelivery logo

No comments:

Post a Comment

AI's Next Magnificent Seven

Here's how much you would have made on the ORIGINAL Magnificent Seven ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ...